OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - SANOFI Share Price

Certificat

DE000CL7PR11

Real-time Boerse Frankfurt Warrants 16:50:56 20/05/2024 BST
2.07 EUR -0.96% Intraday chart for OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - SANOFI
Current month-2.34%
1 month+35.71%
Date Price Change
20/05/24 2.07 -0.96%
17/05/24 2.09 -2.34%
16/05/24 2.14 -2.28%
15/05/24 2.19 -5.19%
14/05/24 2.31 -5.33%

Real-time Boerse Frankfurt Warrants

Last update May 20, 2024 at 04:50 pm

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Société Générale Société Générale
WKN CL7PR1
ISINDE000CL7PR11
Date issued 08/04/2020
Strike 68.58
Maturity Unlimited
Parity 10 : 1
Emission price 1.51
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.93
Lowest since issue 0.73
Spread 0.01
Spread %0.48%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
89.17 EUR
Average target price
108.3 EUR
Spread / Average Target
+21.49%
Consensus